HLA
BIND

Hamilton Lane Advisors’s BIND THERAPEUTICS INC BIND Stock Holding History

Hamilton Lane Advisors’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-12,500
Closed -$69K – 80
2015
Q1 		$69K Buy
+12,500
New +$76.8K 0.03% 49
2014
Q4 		– Sell
-36,500
Closed -$314K – 75
2014
Q3 		$314K Buy
+36,500
New +$360K 0.1% 47

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Hamilton Lane Advisors's BIND Position: Q2 2015 in Review

Hamilton Lane Advisors sold out of BIND THERAPEUTICS INC (BIND) in Q2 2015, closing a stake of 12,500 shares — an estimated $69K sold.

Hamilton Lane Advisors first reported a position in BIND in Q3 2014 and held it in 2 quarters. The position peaked at $314K in Q3 2014. 36 funds tracked by Wall St. Rank hold BIND as of Q2 2015.

  • Hamilton Lane Advisors reported no remaining BIND THERAPEUTICS INC position as of Q2 2015 after selling out during the quarter.
  • Hamilton Lane Advisors sold 12,500 BIND THERAPEUTICS INC shares in Q2 2015, an estimated $69K.
  • Hamilton Lane Advisors first reported a position in BIND THERAPEUTICS INC in Q3 2014 and held it in 2 quarters.
  • Hamilton Lane Advisors's BIND THERAPEUTICS INC position peaked at $314K in Q3 2014.
  • 36 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2015.

Based on Hamilton Lane Advisors's 13F filing for Q2 2015, filed 23 Jul 2015.